VibroniX

Medical Devices & EquipmentSeries BSuzhou, Chinavibronixinc.com

Latest round

Series B

Last raised

Sep 2026

Total raised

$14M

Investors

5

About VibroniX

, trading as VibroniX, is a spectral analysis instrument developer, mainly providing innovative application services of molecular vibration spectroscopy technology. The co-founders, Pu Wang, graduated from Weldon School of Biomedical Engineering at Purdue University, and Jixin Cheng, graduated from Boston University. It has cooperated with Purdue University, Massachusetts General Hospital, and ParkView Health. VibroniX has set up 2 subsidiaries, over 10 core patents, medical device quality system certification and GMP system certification. VibroniX has independently developed coherent Raman technology platform, transient absorption technology platform and transient laser infrared technology platform. Its core products are LipoPAT, AcuSee, and AcouStar. The company's products can be used in life science scenarios such as tumor research, synthetic biology research and production quality control scenarios, material science scenarios such as graphene, organic optoelectronic materials, and environmental science scenarios such as environmental testing. The company generates revenue by providing spectral analysis and imaging products and precision medical diagnostic platforms.

Who invested in VibroniX

5 investors across 2 rounds

See all investors in VibroniX

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Sep 14, 2026

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Jun 24, 2024

    Amount

    $14M

    Investors

    Locked

Questions about VibroniX

Who invested in VibroniX?

VibroniX has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has VibroniX raised?

VibroniX has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did VibroniX last raise money?

VibroniX's most recent round on record is a Series B, in Sep 2026.

What does VibroniX do?

, trading as VibroniX, is a spectral analysis instrument developer, mainly providing innovative application services of molecular vibration spectroscopy technology.

Where is VibroniX headquartered?

VibroniX is headquartered in Suzhou, China.

Which VCs invest in companies like VibroniX?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at VibroniX's stage. Their profiles are linked below.

Raising like VibroniX? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.